Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07115862 · ClinicalTrials.gov registry record · NA
Effects of Pomegranate Juice on Ulcerative Colitis
A NA study of Ulcerative Colitis (Disorder), sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT07115862 is a NA study of Ulcerative Colitis (Disorder) that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07115862, a NA study of Ulcerative Colitis (Disorder), is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will: 1. lower inflammation (in the gut as well as generally in the body) and improve your overall quality of life 2. affect the microbes living in the gut (gut microbiota)
Conditions Studied
Interventions
- OTHER pomegranate juice -> habitual diet
- OTHER habitual diet -> pomegranate juice
Study Locations (2)
California
- West Los Angeles VA Medical Center - Los Angeles
- UCLA Center for Human Nutrition - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2027-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07115862
The ClinicalTrials.gov registry entry for NCT07115862 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis (Disorder) appearing as the primary indexed condition, and to 2 interventions - of which pomegranate juice -> habitual diet is the first listed.
NCT07115862 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07115862 about?
NCT07115862 is a clinical study titled "Effects of Pomegranate Juice on Ulcerative Colitis". The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will: 1. lower inflammation (in the gut as well as generally in the body) and improve your overall quality of life 2. affect the microbes living in the gut (gut microbiota)
What is the current status of trial NCT07115862?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-15. Estimated completion is 2027-10-15.
What conditions does trial NCT07115862 study?
This clinical trial studies the following conditions: Ulcerative Colitis (Disorder).
What interventions are being tested in trial NCT07115862?
The interventions under investigation include: pomegranate juice -> habitual diet (OTHER), habitual diet -> pomegranate juice (OTHER).
Who is sponsoring clinical trial NCT07115862?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07115862 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis (Disorder)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.